Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Diabetic Nephropathy without Diabetes.

López-Revuelta K, Abreu AA, Gerrero-Márquez C, Stanescu RI, Marín MI, Fernández EP.

J Clin Med. 2015 Jul 9;4(7):1403-27. doi: 10.3390/jcm4071403. Review.

2.

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.

Rabasco C, Cavero T, Román E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernández-Juarez G, González F, Ávila A, Baltar JM, Díaz M, Alegre R, Elías S, Antón M, Frutos MA, Pobes A, Blasco M, Martín F, Bernis C, Macías M, Barroso S, de Lorenzo A, Ariceta G, López-Mendoza M, Rivas B, López-Revuelta K, Campistol JM, Mendizábal S, de Córdoba SR, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN).

Kidney Int. 2015 Nov;88(5):1153-60. doi: 10.1038/ki.2015.227. Epub 2015 Jul 29.

PMID:
26221755
3.

Silent diabetic nephropathy.

López-Revuelta K, Galdo PP, Stanescu R, Parejo L, Guerrero C, Pérez-Fernández E.

World J Nephrol. 2014 Feb 6;3(1):6-15. doi: 10.5527/wjn.v3.i1.6.

4.

Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).

Martínez-Castelao A, Gòrriz JL, Garcia-López F, López-Revuelta K, De Alvaro F, Cruzado JM; Spanish CALVIDIA Study Group.

J Nephrol. 2004 Jul-Aug;17(4):544-51.

PMID:
15372417
5.

Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA Study).

López Revuelta K, García López FJ, de Alvaro Moreno F, Alonso J.

Nephrol Dial Transplant. 2004 Sep;19(9):2347-53. Epub 2004 Jul 13.

PMID:
15252167

Supplemental Content

Loading ...
Support Center